DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Andus T, Kocjan A, Muser M. et al.
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Inflamm Bowel Dis 2010;
16: 1947-1956

Andus T, Kocjan A, Muser M. et al.
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Inflamm Bowel Dis 2010;
16: 1947-1956

Download Bibliographical Data

Search in:
Access: